These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21607984)

  • 21. Malignant hyperthermia: a potentially fatal complication of anesthesia.
    Stolworthy C; Haas RE
    Semin Perioper Nurs; 1998 Jan; 7(1):58-66. PubMed ID: 9510843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malignant hyperthermia: pharmacology of triggering.
    Hopkins PM
    Br J Anaesth; 2011 Jul; 107(1):48-56. PubMed ID: 21624965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ryanodine on skeletal muscle lactate and pyruvate in malignant hyperthermia-susceptible and normal swine as assessed by microdialysis.
    Bina S; Muldoon S; Bünger R
    Eur J Anaesthesiol; 2008 Jan; 25(1):48-57. PubMed ID: 17686208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No response to trigger agents in a malignant hyperthermia-susceptible patient.
    Claxton BA; Cross MH; Hopkins PM
    Br J Anaesth; 2002 Jun; 88(6):870-3. PubMed ID: 12173209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 20-Year-Old-Trauma Patient With Suspected Malignant Hyperthermia Following Induction With Succinylcholine: A Case Study.
    Luckey-Smith K; High K
    Adv Emerg Nurs J; 2018; 40(3):171-175. PubMed ID: 30059371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mild variant of malignant hyperthermia following succinylcholine and halogenated agent exposure].
    Fernández-García V; Bermejo MA; Vázquez C; Pereda MJ; Altarriba JM; Alvarez E
    Rev Esp Anestesiol Reanim; 1995 Nov; 42(9):401-2. PubMed ID: 8584782
    [No Abstract]   [Full Text] [Related]  

  • 27. Suxamethonium stands the test of time: it is too early to say goodbye.
    Umesh G; Jasvinder K; Shetty N
    Anaesthesia; 2009 Sep; 64(9):1023; author reply 1023-4. PubMed ID: 19686492
    [No Abstract]   [Full Text] [Related]  

  • 28. Myotonias and masseter spasm: not malignant hyperthermia?
    Gronert GA
    Anesthesiology; 1995 Dec; 83(6):1382-3. PubMed ID: 8533946
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanism of action of muscle relaxants].
    Nishimura N; Yoshino M
    Masui; 1971 Feb; 20(2):160-5. PubMed ID: 4251038
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biology of malignant hyperthermia: a disease of the calcium channels of the skeletal muscle].
    Monnier N; Lunardi J
    Ann Biol Clin (Paris); 2000; 58(2):147-56. PubMed ID: 10760701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant hyperthermia and muscular dystrophies.
    Gurnaney H; Brown A; Litman RS
    Anesth Analg; 2009 Oct; 109(4):1043-8. PubMed ID: 19762730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Several interacting genes influence the malignant hyperthermia phenotype.
    Robinson R; Hopkins P; Carsana A; Gilly H; Halsall J; Heytens L; Islander G; Jurkat-Rott K; Müller C; Shaw MA
    Hum Genet; 2003 Feb; 112(2):217-8. PubMed ID: 12522565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1983 Apr; 32(4):141-57. PubMed ID: 6349413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Potential of succinylcholine-induced neuromuscular blockade by nitrous oxide].
    Tsuchiya A
    Masui; 1995 Dec; 44(12):1608-13. PubMed ID: 8583653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The myotonias and susceptibility to malignant hyperthermia.
    Parness J; Bandschapp O; Girard T
    Anesth Analg; 2009 Oct; 109(4):1054-64. PubMed ID: 19762732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant hyperthermia--diagnostics, treatment and anaesthetic management].
    Schuster F; Müller-Reible CR
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):758-63; quiz 764. PubMed ID: 19918708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins alter intracellular calcium homeostasis in malignant hyperthermia susceptible individuals.
    Metterlein T; Schuster F; Tadda L; Hager M; Roewer N; Anetseder M
    Cardiovasc Ther; 2010 Dec; 28(6):356-60. PubMed ID: 20955541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation.
    Hogan KJ; Vladutiu GD
    Anesth Analg; 2009 Oct; 109(4):1070-2. PubMed ID: 19762733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of succinylcholine in an organotypic spinal cord-skeletal muscle coculture of embryonic mice.
    Drexler B; Thiermann H; Antkowiak B; Grasshoff C
    Chem Biol Interact; 2013 Dec; 206(3):555-60. PubMed ID: 23838346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro response of neuromuscular blockers after chronic carbamazepine treatment in rats.
    Nguyen A; Ramzan I
    Pharmazie; 2000 Dec; 55(12):957. PubMed ID: 11189879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.